Report Description

Global protein assays market will undergo a vigorous growth in the forecast period, 2024-2028. The principal factor behind this market growth is the rigorous research and development taking place in proteomics. For example, a brand-new category of synthetic peptides, better known as mini proteins, were developed by some scientists working at the Indian Institute of Science (IISc), Bangalore in June 2022. According to a few researchers, these mini proteins have the potential to neutralize SARS-CoV-2 like viruses. Moreover, based on a work from the journal Nature Chemical Biology, it has come into picture that these mini proteins can inhibit the virus from entering the host cell. Also, they can clutch the virus particles together in order to deteriorate their ability to cause infection. This progress in research can positively impact the growth of the global protein assays market.

During the forecast period, market expansion is going to be supported by increased expenditures made by leading players in the development of cutting-edge & efficient medications & diagnostic instruments. For instance, Bruker Corp. introduced the two new timsTOF instruments in June 2021. It makes new techniques and uses possible, such as the unbiased, deep multi-omic biomarker discovery process and epiproteomics/PTM characterization. Additionally, they further develop & facilitate these cutting-edge applications & techniques in cancer liquid biopsy research.

Protein Assays for Cancer Diagnosis

Opportunities for disease diagnosis, classification, and monitoring are provided by protein analysis. An assay must fulfil specific requirements in order to be therapeutically relevant. To begin with, it must be capable of detecting the desired protein or proteins. An assay also needs to be specific to the protein it is meant to detect in addition to being sensitive. These tests must also work with readily accessible patient samples in order to be effective. Additionally, laboratory staff must be properly trained to carry out these processes, and the assay's equipment must be easily obtainable in clinical settings. Moreover, assays must be efficient in terms of labor and cost, as well as robust enough to produce data that can be compared across laboratories and staff.

Numerous protein assays based on flow cytometry, enzyme linked-immunosorbent assay (ELISA) and immunohistochemistry (IHC) are employed for the detection, prognosis, and treatment of cancer. These methods can detect over 100 distinctive proteins (not all cancer related). Immunohistochemistry has found its best application in detecting Her2 marker and estrogen receptor in patients with breast cancer. ELISA is another remarkable method to identify cancer biomarkers in blood. This method can detect several markers at the same time with high specificity and sensitivity. For instance, 99.4% specificity and 95.3% sensitivity were reported from a six marker ELISA developed for ovarian cancer.

Therefore, the increasing cancer cases across the globe and their detection can escalate the global protein assays market considerably.


Download Free Sample Report

Government Funding for Research in Proteomics

Governments of quite a few countries are offering funding to assist new research and development in the field of proteomics. For example, Indian Council of Medical Research (ICMR), Government of India provided a funding to Institute of Bioinformatics (IOB) as well as ICMR-Regional Medical research Centre, NE region, Dibrugarh for a project named “Proteomics and biochemical analysis for identification of novel bio- markers for predicting pregnancy induced hypertension (PIH): In a health and demographic cohort from Dibrugarh.” The IOB will be conducting protein analysis of urine samples of pregnant women in distinctive trimesters. The chief aim of this project is to develop a protein marker for the timely detection of PIH.

Furthermore, the Clinical Proteomic Tumor Analysis Consortium (CPTAC) served as an inspiration for funding that was announced by the National Cancer Institute’s (NCI) Small Business Innovation Research (SBIR) Development Center in August 2020. The announcement calls for the development of high-throughput single-cell proteome discovery technologies. This opportunity aims to improve our understanding of how cancer begins and spreads while also facilitating the discovery of powerful cancer biomarkers and their clinical utilization on a micro-scale.

In addition, Genome Canada and Genome BC offered a funding amount of over 18 million for protein research in the year 2018. This funding resulted in the development of novel diagnostic and treatment approaches for different diseases.

These fundings can offer lucrative opportunities for the global protein assays market.

Recent Developments

  • A medical life science company, PerkinElmer, Inc. launched two assay kits named homogenous time-resolved fluorescence (HTRF) and AlphalLISA in April 2022. These kits are meant for a timely detection and quantification of Chinese hamster ovary (CHO) host cell protein (HCP) impurities.
  • A proteomic platform, providing biological understanding for the purpose of research and development to the pharmaceutical as well as diagnostic firms was launched by a leading proteomics company, Biognosys in March 2022.
  • Eli Lilly and Company acquired Protomer Technologies in July 2021.
  • GeoMx DSP Protein Assays was launched by NanoString Technologies, Inc., a biotech company in November 2020.

Market Segmentation

Global protein assays market is segmented on the basis of type, product, technology, application, end user, and region. Based on type, the market is categorized into dye binding assays, test strip-based assays, copper-ion-based assays, and others. Based on product, the market is divided into reagents, kits, and instruments & accessories. On the basis of technology, the market is fragmented into calorimetric protein assays, fluorescence-based protein assays, and absorbance-based protein assays. Based on application, the market can be divided into drug discovery and development, disease diagnosis, and others. On the basis of end user, the market can be further segmented into pharmaceutical and biotechnology companies, clinical laboratories, hospitals, academic research institutes, and others.

Company Profiles

The major players in the global protein assays market are Becton Dickinson and Co, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc, Merck KGaA, Abcam PLC, PerkinElmer Inc., QIAGEN NV, Lonza Group AG, Bio-Techne Corp, Illumina Inc, among others.

Attribute

Details

Base Year

2022

Historical Years

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million and CAGR for 2018-2022 and 2023-2028

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

Type

Product

Technology

Application

End User

Regional Scope

Asia Pacific; Europe; North America; South America; Middle East & Africa

Country Scope

China; India; Japan; South Korea; Australia; France; Germany; United Kingdom; Italy; Spain; United States; Mexico; Canada; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE

Key Companies Profiled

Becton Dickinson and Co, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc, Merck KGaA, Abcam PLC, PerkinElmer Inc., QIAGEN NV, Lonza Group AG, Bio-Techne Corp, Illumina Inc.

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global protein assays market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         Protein Assays Market, By Type:

    • Dye Binding Assays
    • Test Strip-Based Assays
    • Copper-Ion-Based Assays
    • Others
  • Protein Assays Market, By Product:
    • Reagents
    • Kits
    • Instruments and Accessories
  • Protein Assays Market, By Technology:
    • Colorimetric Protein Assays
    • Fluorescence-Based Protein Assays
    • Absorbance-Based Protein Assays
  • Protein Assays Market, By Application:
    • Drug Discovery and Development
    • Disease Diagnosis
    • Others
  • Protein Assays Market, By End User:
    • Pharmaceutical and Biotechnology Companies
    • Clinical Laboratories
    • Hospitals
    • Academic Research Institutes
    • Others
  • Protein Assays Market, By Region:
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
    • North America
      • United States
      • Mexico
      • Canada
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global protein assays market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Protein Assays Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Clinical Trial Analysis

5.1.  Ongoing Clinical Trials

5.2.  Completed Clinical Trials

5.3.  Terminated Clinical Trials

5.4.  Breakdown of Pipeline, By Development Phase

5.5.  Breakdown of Pipeline, By Status

5.6.  Breakdown of Pipeline, By Study Application

5.7.  Breakdown of Pipeline, By Region

5.8.  Clinical Trials Heat Map

6.    Patents Analysis

7.    Global Protein Assays Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)

7.2.2.     By Product (Reagents, Kits, Instruments and Accessories)

7.2.3.     By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)

7.2.4.     By Application (Drug Discovery and Development, Disease Diagnosis, Others)

7.2.5.     By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)

7.2.6.     By Region

7.2.7.     By Company (2022)

7.3.  Product Market Map

7.3.1.     By Type

7.3.2.     By Product

7.3.3.     By Technology

7.3.4.     By Application

7.3.5.     By End User

7.3.6.     By Region

8.    Asia-Pacific Protein Assays Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)

8.2.2.     By Product (Reagents, Kits, Instruments and Accessories)

8.2.3.     By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)

8.2.4.     By Application (Drug Discovery and Development, Disease Diagnosis, Others)

8.2.5.     By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)

8.2.6.     By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.     China Protein Assays Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Type

8.3.1.2.2.             By Product

8.3.1.2.3.             By Technology

8.3.1.2.4.             By Application

8.3.1.2.5.             By End User

8.3.2.     India Protein Assays Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Type

8.3.2.2.2.             By Product

8.3.2.2.3.             By Technology

8.3.2.2.4.             By Application

8.3.2.2.5.             By End User

8.3.3.     Japan Protein Assays Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Type

8.3.3.2.2.             By Product

8.3.3.2.3.             By Technology

8.3.3.2.4.             By Application

8.3.3.2.5.             By End User

8.3.4.     South Korea Protein Assays Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Type

8.3.4.2.2.             By Product

8.3.4.2.3.             By Technology

8.3.4.2.4.             By Application

8.3.4.2.5.             By End User

8.3.5.     Australia Protein Assays Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Type

8.3.5.2.2.             By Product

8.3.5.2.3.             By Technology

8.3.5.2.4.             By Application

8.3.5.2.5.             By End User

9.    Europe Protein Assays Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)

9.2.2.     By Product (Reagents, Kits, Instruments and Accessories)

9.2.3.     By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)

9.2.4.     By Application (Drug Discovery and Development, Disease Diagnosis, Others)

9.2.5.     By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)

9.2.6.     By Country

9.3.  Europe: Country Analysis

9.3.1.     France Protein Assays Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Type

9.3.1.2.2.             By Product

9.3.1.2.3.             By Technology

9.3.1.2.4.             By Application

9.3.1.2.5.             By End User

9.3.2.     Germany Protein Assays Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Type

9.3.2.2.2.             By Product

9.3.2.2.3.             By Technology

9.3.2.2.4.             By Application

9.3.2.2.5.             By End User

9.3.3.     United Kingdom Protein Assays Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Type

9.3.3.2.2.             By Product

9.3.3.2.3.             By Technology

9.3.3.2.4.             By Application

9.3.3.2.5.             By End User

9.3.4.     Italy Protein Assays Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Type

9.3.4.2.2.             By Product

9.3.4.2.3.             By Technology

9.3.4.2.4.             By Application

9.3.4.2.5.             By End User

9.3.5.     Spain Protein Assays Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Type

9.3.5.2.2.             By Product

9.3.5.2.3.             By Technology

9.3.5.2.4.             By Application

9.3.5.2.5.             By End User

10.  North America Protein Assays Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)

10.2.2.  By Product (Reagents, Kits, Instruments and Accessories)

10.2.3.  By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)

10.2.4.  By Application (Drug Discovery and Development, Disease Diagnosis, Others)

10.2.5.  By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)

10.2.6.  By Country

10.3.              North America: Country Analysis

10.3.1.  United States Protein Assays Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Type

10.3.1.2.2.           By Product

10.3.1.2.3.           By Technology

10.3.1.2.4.           By Application

10.3.1.2.5.           By End User

10.3.2.  Mexico Protein Assays Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Type

10.3.2.2.2.           By Product

10.3.2.2.3.           By Technology

10.3.2.2.4.           By Application

10.3.2.2.5.           By End User

10.3.3.  Canada Protein Assays Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Type

10.3.3.2.2.           By Product

10.3.3.2.3.           By Technology

10.3.3.2.4.           By Application

10.3.3.2.5.           By End User

11.  South America Protein Assays Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)

11.2.2.  By Product (Reagents, Kits, Instruments and Accessories)

11.2.3.  By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)

11.2.4.  By Application (Drug Discovery and Development, Disease Diagnosis, Others)

11.2.5.  By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)

11.2.6.  By Country

11.3.              South America: Country Analysis

11.3.1.  Brazil Protein Assays Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Type

11.3.1.2.2.           By Product

11.3.1.2.3.           By Technology

11.3.1.2.4.           By Application

11.3.1.2.5.           By End User

11.3.2.  Argentina Protein Assays Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Type

11.3.2.2.2.           By Product

11.3.2.2.3.           By Technology

11.3.2.2.4.           By Application

11.3.2.2.5.           By End User

11.3.3.  Colombia Protein Assays Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Type

11.3.3.2.2.           By Product

11.3.3.2.3.           By Technology

11.3.3.2.4.           By Application

11.3.3.2.5.           By End User

12.  Middle East and Africa Protein Assays Market Outlook

12.1.              Market Size & Forecast

12.1.1.  By Value

12.2.              Market Share & Forecast

12.2.1.  By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)

12.2.2.  By Product (Reagents, Kits, Instruments and Accessories)

12.2.3.  By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)

12.2.4.  By Application (Drug Discovery and Development, Disease Diagnosis, Others)

12.2.5.  By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)

12.2.6.  By Country

12.3.              MEA: Country Analysis

12.3.1.  South Africa Protein Assays Market Outlook

12.3.1.1.      Market Size & Forecast

12.3.1.1.1.           By Value

12.3.1.2.      Market Share & Forecast

12.3.1.2.1.           By Type

12.3.1.2.2.           By Product

12.3.1.2.3.           By Technology

12.3.1.2.4.           By Application

12.3.1.2.5.           By End User